Form D Explorer

Form D — TenNor Therapeutics (Suzhou) Ltd

0001104659-26-066134 · filed May 26, 2026

Offering

Industry: Biotechnology
Exemptions: 06b
Total offering: $14,699,667
Total sold: $14,699,667
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: TenNor Therapeutics (Suzhou) Ltd
CIK: 2136090
Entity: Corporation
Jurisdiction: CHINA
Year incorporated: —
Address: UNIT 701, BLOCK B7, BIOBAY
SUZHOU, F4 215123
Phone: 008651286861990

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Zhenkun Ma · Executive Officer

Suzhou, F4 Find on LinkedIn ↗
Gaoguang Song · Director

Beijing, F4 Find on LinkedIn ↗
Michael James Bakes · Director

Dallas, TX Find on LinkedIn ↗
Wai Kong Lee · Director

Hong Kong, K3 Find on LinkedIn ↗
Lin Ni · Director

Shanghai, F4 Find on LinkedIn ↗
Leping Li · Director

Shanghai, F4 Find on LinkedIn ↗
Jie Bi · Executive Officer

Suzhou, F4 Find on LinkedIn ↗
Guozhu Geng · Executive Officer

Suzhou, F4 Find on LinkedIn ↗
Jing Chen · Executive Officer

SuzhOu, F4 Find on LinkedIn ↗
Yinjiao Yu · Executive Officer

Suzhou, F4 Find on LinkedIn ↗
Rongping Chen · Executive Officer

Suzhou, F4 Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗